Related Experiment Videos
Stimulation of prolyl hydroxylase activity by bleomycin
The Journal of Antibiotics
|September 1, 1978
Summary
Bleomycin, an anti-cancer drug, significantly enhances prolyl hydroxylase (proline, 2-oxoglutarate dioxygenase) activity. This effect is observed at low ferrous ion concentrations, suggesting a novel interaction with this crucial enzyme.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Prolyl hydroxylase (proline, 2-oxoglutarate dioxygenase) is a key enzyme in collagen synthesis.
- Bleomycin is a glycopeptide antibiotic used in cancer treatment, known to cause pulmonary fibrosis.
- Ferrous ion is an essential cofactor for prolyl hydroxylase activity.
Purpose of the Study:
- To investigate the effect of bleomycin on purified prolyl hydroxylase activity.
- To determine the optimal conditions for bleomycin-mediated enzyme enhancement.
- To explore the mechanism of bleomycin's interaction with prolyl hydroxylase.
Main Methods:
- Enzyme assays were performed using purified prolyl hydroxylase.
- The influence of varying bleomycin and ferrous ion concentrations was assessed.
- The order of addition of reagents and the effect of copper-chelated bleomycin were examined.
Main Results:
- Bleomycin enhanced prolyl hydroxylase activity by 3-8 fold at low ferrous ion concentrations (1 x 10(-5) M).
- Maximum stimulation occurred at 15 microgram/ml bleomycin, equimolar to ferrous ion.
- Bleomycin shifted the optimal ferrous ion concentration from 2 x 10(-3) M to 1 x 10(-5) M.
- Copper-chelated bleomycin showed no enhancing effect, indicating the importance of iron complexation.
Conclusions:
- Bleomycin potentiates prolyl hydroxylase activity, particularly under conditions of low ferrous ion availability.
- The interaction appears to involve the chelation of ferrous ions by bleomycin, facilitating enzyme activity.
- This finding may have implications for understanding bleomycin's side effects and developing new therapeutic strategies.